Summit Tx Capital, L.P. Ocugen, Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q2 2025
A detailed history of Summit Tx Capital, L.P. transactions in Ocugen, Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 639,200 shares of OCGN stock, worth $658,376. This represents 0.03% of its overall portfolio holdings.
Number of Shares
639,200Holding current value
$658,376% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding OCGN
# of Institutions
113Shares Held
64.8MCall Options Held
639KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$18.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$15.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$5.21 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.28 Million0.17% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$3.59 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $223M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...